Eton Pharmaceuticals (ETON) News Today $11.23 +0.48 (+4.47%) (As of 11/22/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period What is HC Wainwright's Forecast for ETON FY2024 Earnings?November 19, 2024 | americanbankingnews.comShort Interest in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Drops By 6.2%Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) was the recipient of a significant decrease in short interest in the month of October. As of October 31st, there was short interest totalling 191,900 shares, a decrease of 6.2% from the October 15th total of 204,600 shares. Based on an average daily trading volume, of 156,700 shares, the days-to-cover ratio is currently 1.2 days. Currently, 0.8% of the company's shares are short sold.November 18, 2024 | marketbeat.comHC Wainwright Has Bullish Forecast for ETON FY2024 EarningsEton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Analysts at HC Wainwright upped their FY2024 earnings per share estimates for shares of Eton Pharmaceuticals in a research report issued on Wednesday, November 13th. HC Wainwright analyst S. Ramakanth now forecasts that the company will earNovember 18, 2024 | marketbeat.comEton Pharmaceuticals Third Quarter 2024 Earnings: Beats ExpectationsNovember 16, 2024 | finance.yahoo.comHC Wainwright Issues Negative Forecast for ETON EarningsNovember 16, 2024 | americanbankingnews.comHC Wainwright Brokers Reduce Earnings Estimates for ETONEton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Stock analysts at HC Wainwright reduced their Q1 2025 earnings estimates for Eton Pharmaceuticals in a research report issued on Wednesday, November 13th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earningsNovember 15, 2024 | marketbeat.comEton Pharmaceuticals: Strong Financial Performance and Growth Prospects Drive Buy RatingNovember 13, 2024 | markets.businessinsider.comEton Pharmaceuticals Reports Strong Q3 2024 ResultsNovember 13, 2024 | markets.businessinsider.comHC Wainwright Reaffirms Buy Rating for Eton Pharmaceuticals (NASDAQ:ETON)HC Wainwright reaffirmed a "buy" rating and issued a $11.00 target price on shares of Eton Pharmaceuticals in a report on Wednesday.November 13, 2024 | marketbeat.comEton Pharmaceuticals Inc (ETON) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ...November 13, 2024 | finance.yahoo.comEton Pharmaceuticals reports Q3 EPS 2c, consensus (1c)November 13, 2024 | markets.businessinsider.comEton Pharmaceuticals, Inc. (ETON) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | seekingalpha.comEarnings Outlook For Eton PharmaceuticalsNovember 12, 2024 | benzinga.comEton Pharmaceuticals Reports Third Quarter 2024 Financial ResultsNovember 12, 2024 | globenewswire.comWhat To Expect From Eton Pharmaceuticals Inc (ETON) Q3 2024 EarningsNovember 11, 2024 | finance.yahoo.comEton Pharmaceuticals awarded second patent for ET-400November 8, 2024 | markets.businessinsider.comEton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)November 8, 2024 | markets.businessinsider.comEton Pharmaceuticals (ETON) Scheduled to Post Earnings on TuesdayEton Pharmaceuticals (NASDAQ:ETON) will be releasing earnings after the market closes on Tuesday, November 12, Zacks reports.November 7, 2024 | marketbeat.comEton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024November 6, 2024 | globenewswire.comEton Pharmaceuticals (ETON) Gets a Buy from Craig-HallumOctober 29, 2024 | markets.businessinsider.comEton Pharmaceuticals price target raised to $15 from $10 at Craig-HallumOctober 29, 2024 | finance.yahoo.comOpaleye Management Inc. Reduces Stake in Eton Pharmaceuticals Inc.October 28, 2024 | finance.yahoo.comCraig Hallum Raises Eton Pharmaceuticals (NASDAQ:ETON) Price Target to $15.00Craig Hallum raised their price target on shares of Eton Pharmaceuticals from $10.00 to $15.00 and gave the stock a "buy" rating in a research report on Monday.October 28, 2024 | marketbeat.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest UpdateEton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) saw a significant growth in short interest during the month of October. As of October 15th, there was short interest totalling 204,600 shares, a growth of 62.0% from the September 30th total of 126,300 shares. Approximately 0.8% of the company's stock are short sold. Based on an average daily trading volume, of 134,300 shares, the short-interest ratio is presently 1.5 days.October 27, 2024 | marketbeat.comAnalysts Expect Breakeven For Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Before LongOctober 15, 2024 | finance.yahoo.com3 Stocks Insiders Are Buying Heavily in October and WhyOctober 10, 2024 | investing.comOpaleye Management Inc. Bolsters Portfolio with Strategic Acquisition of Eton Pharmaceuticals SharesOctober 10, 2024 | finance.yahoo.comOpaleye Management Inc. Purchases 11,248 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) StockOctober 9, 2024 | insidertrades.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Major Shareholder Opaleye Management Inc. Purchases 11,248 SharesEton Pharmaceuticals, Inc. (NASDAQ:ETON - Get Free Report) major shareholder Opaleye Management Inc. acquired 11,248 shares of the business's stock in a transaction on Monday, October 7th. The shares were bought at an average cost of $7.22 per share, with a total value of $81,210.56. Following the completion of the acquisition, the insider now owns 2,730,000 shares in the company, valued at approximately $19,710,600. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.October 8, 2024 | marketbeat.comEton Pharmaceuticals stock target raised by H.C. Wainwright on Increlex acquisitionOctober 6, 2024 | investing.comEton Pharmaceuticals (NASDAQ:ETON) Stock, Short Interest ReportOctober 6, 2024 | benzinga.comEton Pharmaceuticals (NASDAQ:ETON) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comCraig-Hallum Gives a Buy Rating to Eton Pharmaceuticals (ETON)October 4, 2024 | markets.businessinsider.comEton Pharmaceuticals (NASDAQ:ETON) PT Raised to $10.00 at Craig HallumCraig Hallum raised their target price on Eton Pharmaceuticals from $8.00 to $10.00 and gave the company a "buy" rating in a report on Friday.October 4, 2024 | marketbeat.comEton Pharma To Buy SPIGFD Drug Increlex From IpsenOctober 3, 2024 | markets.businessinsider.comEton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from IpsenOctober 3, 2024 | globenewswire.comAristides Capital LLC Purchases Shares of 200,000 Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Aristides Capital LLC purchased a new position in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 200,000 shares of the company's stock, valuedOctober 1, 2024 | marketbeat.comThompson Siegel & Walmsley LLC Acquires Shares of 127,724 Eton Pharmaceuticals, Inc. (NASDAQ:ETON)Thompson Siegel & Walmsley LLC bought a new position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 127,724 shares of the company's stock, valued at appSeptember 17, 2024 | marketbeat.comCombination treatment improves symptoms of agitated delirium in end-of-life cancer patientsSeptember 16, 2024 | msn.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Major Shareholder Purchases $267,375.00 in StockSeptember 13, 2024 | insidertrades.comOpaleye Management Inc. Increases Stake in Eton Pharmaceuticals Inc.September 13, 2024 | finance.yahoo.comEquities Analysts Set Expectations for Eton Pharmaceuticals, Inc.'s Q3 2024 Earnings (NASDAQ:ETON)Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Research analysts at HC Wainwright issued their Q3 2024 EPS estimates for shares of Eton Pharmaceuticals in a note issued to investors on Wednesday, September 4th. HC Wainwright analyst R. Selvaraju anticipates that the company will earn ($September 6, 2024 | marketbeat.comHC Wainwright Comments on Eton Pharmaceuticals, Inc.'s FY2025 Earnings (NASDAQ:ETON)Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Stock analysts at HC Wainwright issued their FY2025 earnings per share estimates for Eton Pharmaceuticals in a note issued to investors on Wednesday, September 4th. HC Wainwright analyst R. Selvaraju expects that the company will earn $0.31September 5, 2024 | marketbeat.comEton Pharmaceuticals: A Strong Buy on Niche Market Leadership and Robust Growth ProspectsSeptember 5, 2024 | markets.businessinsider.comEton Pharmaceuticals (NASDAQ:ETON) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $9.00 target price on shares of Eton Pharmaceuticals in a research note on Wednesday.September 4, 2024 | marketbeat.comEton Pharmaceuticals (NASDAQ:ETON) Trading 2.7% Higher Eton Pharmaceuticals (NASDAQ:ETON) Trading 2.7% HigherAugust 23, 2024 | marketbeat.comEton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment ConferenceAugust 22, 2024 | globenewswire.comETON Sep 2024 5.000 put (ETON240920P00005000)August 19, 2024 | finance.yahoo.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | msn.comEton Pharmaceuticals, Inc. (ETON) Q2 2024 Earnings Call TranscriptAugust 11, 2024 | seekingalpha.com Get Eton Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. ETON Media Mentions By Week ETON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETON News Sentiment▼0.410.50▲Average Medical News Sentiment ETON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETON Articles This Week▼72▲ETON Articles Average Week Get Eton Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LXRX News ASMB News GLYC News SLGL News GYRE News APLT News COGT News COLL News BCYC News PAHC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ETON) was last updated on 11/24/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored#1 Crypto of 2024Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eton Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eton Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
